We’ve developed a new way to see these costs which illustrates why they’ve not been prioritized like those of Diabetes.
Asthma and COPD are widespread in the U.S., affecting over 40 million Americans. These conditions are leading causes of morbidity and have significant impacts on quality of life.
The annual healthcare costs associated with asthma and COPD in the United States exceed $100 billion. This high expense is largely driven by hospitalizations and emergency department visits due to exacerbations of these conditions.
The Nightingale Virtual Respiratory Care Program utilizes an innovative approach to manage chronic respiratory diseases. It emphasizes self-management and actualization for patients, aiming to optimize clinical outcomes, reduce costs, and improve quality of life.